Archives

by in
Entry Author Date Location
With Novartis Deal Dead, Proteon Embarks on Plan B With $45M Round 05/16/14 Boston
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
Vaccine Developer Genocea Prices IPO at $12 Per Share 02/05/14 Boston
Dicerna Shares Triple on First Trading Day, Close at $46 01/30/14 Boston
Dicerna Prices Upsized IPO at $15 Per Share, Starts Trading Thursday 01/29/14 Boston
Dicerna Joins Biotech IPO Queue, Plans $69M Raise 01/02/14 Boston
Vaccine Developer Genocea Files For IPO, Plans to Raise $75M 12/23/13 Boston
Sutro Biopharma Garners $26,000,000 Series D Funding 12/11/13 San Francisco
The Biggest Bargains Pharma Scooped Up in the Down Years 10/28/13 National
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
Dicerna Snags $60M as RNAi Heats Up Again 08/01/13 Boston
Dicerna Pharmaceuticals Obtains $60,000,000 Series C Funding 08/01/13 Boston
Enanta, Tetraphase Go Public in Boston Biotech IPO Madness 03/21/13 Boston
Crescendo Bioscience Snags $28M For Arthritis Test 01/03/13 San Francisco
Crescendo Bioscience Garners $28,000,000 Series D Financing Round 01/03/13 San Francisco
Sutro Strikes Celgene Deal Worth Up to $500M 12/18/12 San Francisco
Exclusive: Skyline Ventures Cuts Partners, Postpones Fundraising 10/26/12 National
Genocea Biosciences Secures $30,000,000 Series C Financing 10/10/12 Boston
Sutro Biopharma Pulls in $16M for New Antibody Drugs 05/08/12 San Francisco
Sutro Biopharma Lands $16,500,000 Series C Funding 05/08/12 San Francisco
Collegium Pharmaceutical Receives $22,500,000 New Funding Round 02/22/12 Boston
Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News 10/14/11 Boston
Report: Tolerx Folds Its Tent, After $150M in Investment and a Failed Diabetes Drug Trial 10/07/11 Boston
SI-Bone Secures $16,000,000 New Financing Round 09/26/11 San Francisco
Tolerx and Glaxo Diabetes Drug Disappoints in Late-Stage Study 03/11/11 Boston
AcelRx Prices IPO 01/21/11 San Francisco
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News 01/07/11 Boston
SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News 01/05/11 Boston
Genocea Biosciences Raises $35M from J&J and Others for Vaccines Business 01/03/11 Boston
Genocea Biosciences Obtains $35,000,000 Series B Funding Round 01/03/11 Boston
Page 1 of 3 next page »